Font Size:
a
A
A
Keyword [TKIs resistance]
Result: 21 - 29 | Page: 2 of 2
21.
Correlation Between Clinical Features Of Patients With Advanced NSCLC After The First Generation EGFR-TKIS Resistance And T790M Mutation,the Efficacy Of Osimertinib
22.
Effect Of Silencing FGL1 On Sensitivity Of Gefitinib In Lung Adenocarcinoma Cells
23.
Observation On The Efficacy Of Three Treatment Options For T790M Negative Advanced NSCLC Patients After First Generation EGFR-TKIs Resistance
24.
Investigation On The Mechanism Of PIK3CA Mutation To EGFR-TKIs Resistance In Non-small Cell Lung Cancer
25.
HGF Induces EGFR-TKIs Resistance In Different Genotypes Of NSCLC And Reversal Effect Of C-Met Inhibitors
26.
Evolution Of Immune Microenvironment And Mechanism Of Drug Resistance In EGFR L858R/T790M Co-mutant Non-small Cell Lung Cancer With Osimertinib Treatment
27.
Identification Of Key Functional LncRNAS And Genes In The EGFR-TKIs Resistance Susceptibility Chromosome 4q12 Loci In Non-small Cell Lung Cancer
28.
Research On Effect And Mechanism Of Phosphoserine Aminotransferase 1 In EGFR-TKIs Resistance In Lung Adenocarcinoma
29.
Observation On The Efficacy Of Osimertinib Combined With Anti-angiogenic Drugs In Advanced NSCLC Patients With T790M Mutation After First-generation EGFR-TKIs Resistance
<<First
<Prev
Next>
Last>>
Jump to
